Propionibacterium acnes
- Clinical TherapeuticsMicrobiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris
Sarecycline is the first narrow-spectrum tetracycline-class antibiotic being developed for acne treatment. In addition to exhibiting activity against important skin/soft tissue pathogens, sarecycline exhibits targeted antibacterial activity against clinical isolates of Cutibacterium acnes.
- Experimental TherapeuticsActivity of Electrical Current in Experimental Propionibacterium acnes Foreign-Body Osteomyelitis
- Experimental TherapeuticsActivity of an Antimicrobial Hydrocephalus Shunt Catheter against Propionibacterium acnes
- Mechanisms of Action: Physiological EffectsActivity of the Novel Macrolide BAL19403 against Ribosomes from Erythromycin-Resistant Propionibacterium acnes
- LETTERS TO THE EDITORSusceptibilities of Propionibacterium acnesOphthalmic Isolates to Moxifloxacin